Fundraising Fox1 people tracked
Find your way into Avedro, Inc.
Sign up to see every warm intro you have to Avedro, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avedro, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
The foundation advances its parent company's mission to deliver transformative therapies for glaucoma, corneal, and retinal diseases by providing the less fortunate with access to meaningful, safe, and long-term ophthalmic care. Operating through partnerships with over 158 humanitarian organizations, it has contributed more than 9,000 IOP-lowering products and stents to underserved glaucoma patients across 62 countries.
Source: firm website, verified Aug 5, 2026.
Team · 1 people
from public directories
Founder mafia
2 people who came through Avedro, Inc. went on to found or lead other companies.
What they invest in
from 4 of 6 portfolio companiesBiotech ×3Healthtech ×3Medical Devices ×3Digital Health ×2
HQs:United States×3
Investments · 6 tracked
founders shown can be your intro pathBy year:2012 · 22010 · 13 dated
Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms.
BiotechHealthtechMedical DevicesAliso Viejo, US
Thomas W. Burns(Chief Executive Officer and Chairman of the Board)
Co-investorsMontreux Equity Partners
iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
BiotechDigital HealthHealthtechMedical Devices
Sophisticated optics for illumination and enhanced visualization in surgical procedures.
HealthtechSan Francisco, US
Kenneth Trauner(Executive Officer, Director)Alex Vayser(Executive Officer)Philip Sawyer(Executive Officer, Director)inTheresa Brandner-Allen(Executive Officer)Brett Robertson(Executive Officer)Doug Rimer(Executive Officer)
Co-investorsAlpine MeridianWindham Capital PartnersHEALTHCARE ROYALTY PARTNERSKleiner PerkinsValence Advantage Life SciencesWellington Management
iDose TR is a treatment for open-angle glaucoma and high eye pressure.
BiotechDigital HealthMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Obalon TherapeuticsRevision Optics
Exits · 1
1 IPOsGlaukosNYSE: GKOS
Frequently asked questions
- How many investments has Avedro, Inc. made?
- Avedro, Inc. has 6 tracked investments, 1 of which have exited.
- What sectors does Avedro, Inc. focus on?
- Avedro, Inc. focuses on Healthtech, Medical Devices.
Co-investors · 4
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
Firms observed investing alongside Avedro, Inc., from public investor directories. Shared companies are the overlap with Avedro, Inc.'s recorded portfolio.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.